New weight-loss drug shows promise in treating sleep apnea, according to drugmaker

The Dallas Express News

Right

Mixed Factuality

New weight-loss drug shows promise in treating sleep apnea, according to drugmaker

Eli Lilly announced last week that its latest weight-loss drug, Zepbound, may also benefit individuals with sleep apnea. The drugmaker has been running clinical trials testing the effectiveness of Zepbound, which the FDA approved to treat obesity in November, in treating a breathing disorder affecting an estimated 39 million Americans. A news release indicated that a phase-3 trial involving over 400 obese people with sleep apnea showed that taki…